Global and United States Alzheimer’s Therapeutic Market Insights, Forecast to 2027
SKU ID : QYR-18789118 | Publishing Date : 23-Jul-2021 | No. of pages : 142
Detailed TOC of Global and United States Alzheimer’s Therapeutic Market Insights, Forecast to 2027
1 Study Coverage1.1 Alzheimer’s Therapeutic Product Introduction
1.2 Market by Type
1.2.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Type
1.2.2 Memantine Hydrochloride
1.2.3 Donepezil Hydrochloride
1.2.4 Rivastigmine
1.2.5 Galantamine Hydrobromide
1.3 Market by Application
1.3.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alzheimer’s Therapeutic Market Size, Estimates and Forecasts
2.1.1 Global Alzheimer’s Therapeutic Revenue 2016-2027
2.1.2 Global Alzheimer’s Therapeutic Sales 2016-2027
2.2 Global Alzheimer’s Therapeutic, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Alzheimer’s Therapeutic Historical Market Size by Region (2016-2021)
2.3.1 Global Alzheimer’s Therapeutic Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Alzheimer’s Therapeutic Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Alzheimer’s Therapeutic Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Alzheimer’s Therapeutic Sales Forecast by Region (2022-2027)
2.4.2 Global Alzheimer’s Therapeutic Revenue Forecast by Region (2022-2027)
3 Global Alzheimer’s Therapeutic Competitor Landscape by Players
3.1 Global Top Alzheimer’s Therapeutic Manufacturers by Sales
3.1.1 Global Alzheimer’s Therapeutic Sales by Manufacturer (2016-2021)
3.1.2 Global Alzheimer’s Therapeutic Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Alzheimer’s Therapeutic Manufacturers by Revenue
3.2.1 Key Alzheimer’s Therapeutic Manufacturers Covered: Ranking by Revenue
3.2.2 Global Alzheimer’s Therapeutic Revenue by Manufacturers (2016-2021)
3.2.3 Global Alzheimer’s Therapeutic Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Alzheimer’s Therapeutic Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Alzheimer’s Therapeutic Revenue in 2020
3.2.6 Global Alzheimer’s Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Alzheimer’s Therapeutic Price by Manufacturers
3.4 Global Alzheimer’s Therapeutic Manufacturing Base Distribution, Product Types
3.4.1 Alzheimer’s Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alzheimer’s Therapeutic Product Type
3.4.3 Date of International Manufacturers Enter into Alzheimer’s Therapeutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Alzheimer’s Therapeutic Market Size by Type (2016-2021)
4.1.1 Global Alzheimer’s Therapeutic Sales by Type (2016-2021)
4.1.2 Global Alzheimer’s Therapeutic Revenue by Type (2016-2021)
4.1.3 Alzheimer’s Therapeutic Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Alzheimer’s Therapeutic Market Size Forecast by Type (2022-2027)
4.2.1 Global Alzheimer’s Therapeutic Sales Forecast by Type (2022-2027)
4.2.2 Global Alzheimer’s Therapeutic Revenue Forecast by Type (2022-2027)
4.2.3 Alzheimer’s Therapeutic Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Alzheimer’s Therapeutic Market Size by Application (2016-2021)
5.1.1 Global Alzheimer’s Therapeutic Sales by Application (2016-2021)
5.1.2 Global Alzheimer’s Therapeutic Revenue by Application (2016-2021)
5.1.3 Alzheimer’s Therapeutic Price by Application (2016-2021)
5.2 Alzheimer’s Therapeutic Market Size Forecast by Application (2022-2027)
5.2.1 Global Alzheimer’s Therapeutic Sales Forecast by Application (2022-2027)
5.2.2 Global Alzheimer’s Therapeutic Revenue Forecast by Application (2022-2027)
5.2.3 Global Alzheimer’s Therapeutic Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
6.1.1 United States Alzheimer’s Therapeutic Sales YoY Growth 2016-2027
6.1.2 United States Alzheimer’s Therapeutic Revenue YoY Growth 2016-2027
6.1.3 United States Alzheimer’s Therapeutic Market Share in Global Market 2016-2027
6.2 United States Alzheimer’s Therapeutic Market Size by Players (International and Local Players)
6.2.1 United States Top Alzheimer’s Therapeutic Players by Sales (2016-2021)
6.2.2 United States Top Alzheimer’s Therapeutic Players by Revenue (2016-2021)
6.3 United States Alzheimer’s Therapeutic Historic Market Review by Type (2016-2021)
6.3.1 United States Alzheimer’s Therapeutic Sales Market Share by Type (2016-2021)
6.3.2 United States Alzheimer’s Therapeutic Revenue Market Share by Type (2016-2021)
6.3.3 United States Alzheimer’s Therapeutic Price by Type (2016-2021)
6.4 United States Alzheimer’s Therapeutic Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Alzheimer’s Therapeutic Sales Forecast by Type (2022-2027)
6.4.2 United States Alzheimer’s Therapeutic Revenue Forecast by Type (2022-2027)
6.4.3 United States Alzheimer’s Therapeutic Price Forecast by Type (2022-2027)
6.5 United States Alzheimer’s Therapeutic Historic Market Review by Application (2016-2021)
6.5.1 United States Alzheimer’s Therapeutic Sales Market Share by Application (2016-2021)
6.5.2 United States Alzheimer’s Therapeutic Revenue Market Share by Application (2016-2021)
6.5.3 United States Alzheimer’s Therapeutic Price by Application (2016-2021)
6.6 United States Alzheimer’s Therapeutic Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Alzheimer’s Therapeutic Sales Forecast by Application (2022-2027)
6.6.2 United States Alzheimer’s Therapeutic Revenue Forecast by Application (2022-2027)
6.6.3 United States Alzheimer’s Therapeutic Price Forecast by Application (2022-2027)
7 North America
7.1 North America Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
7.2 North America Alzheimer’s Therapeutic Market Facts & Figures by Country
7.2.1 North America Alzheimer’s Therapeutic Sales by Country (2016-2021)
7.2.2 North America Alzheimer’s Therapeutic Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
8.2 Asia Pacific Alzheimer’s Therapeutic Market Facts & Figures by Region
8.2.1 Asia Pacific Alzheimer’s Therapeutic Sales by Region (2016-2021)
8.2.2 Asia Pacific Alzheimer’s Therapeutic Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
9.2 Europe Alzheimer’s Therapeutic Market Facts & Figures by Country
9.2.1 Europe Alzheimer’s Therapeutic Sales by Country (2016-2021)
9.2.2 Europe Alzheimer’s Therapeutic Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
10.2 Latin America Alzheimer’s Therapeutic Market Facts & Figures by Country
10.2.1 Latin America Alzheimer’s Therapeutic Sales by Country (2016-2021)
10.2.2 Latin America Alzheimer’s Therapeutic Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Alzheimer’s Therapeutic Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Alzheimer’s Therapeutic Market Facts & Figures by Country
11.2.1 Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2016-2021)
11.2.2 Middle East and Africa Alzheimer’s Therapeutic Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer Inc
12.1.1 Pfizer Inc Corporation Information
12.1.2 Pfizer Inc Description and Business Overview
12.1.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Inc Alzheimer’s Therapeutic Products Offered
12.1.5 Pfizer Inc Recent Development
12.2 Novartis International AG
12.2.1 Novartis International AG Corporation Information
12.2.2 Novartis International AG Description and Business Overview
12.2.3 Novartis International AG Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis International AG Alzheimer’s Therapeutic Products Offered
12.2.5 Novartis International AG Recent Development
12.3 Axovant Sciences Ltd
12.3.1 Axovant Sciences Ltd Corporation Information
12.3.2 Axovant Sciences Ltd Description and Business Overview
12.3.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Products Offered
12.3.5 Axovant Sciences Ltd Recent Development
12.4 Acadia Pharmaceuticals, Inc
12.4.1 Acadia Pharmaceuticals, Inc Corporation Information
12.4.2 Acadia Pharmaceuticals, Inc Description and Business Overview
12.4.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Products Offered
12.4.5 Acadia Pharmaceuticals, Inc Recent Development
12.5 Biotie Therapies
12.5.1 Biotie Therapies Corporation Information
12.5.2 Biotie Therapies Description and Business Overview
12.5.3 Biotie Therapies Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotie Therapies Alzheimer’s Therapeutic Products Offered
12.5.5 Biotie Therapies Recent Development
12.6 Astra Zeneca plc
12.6.1 Astra Zeneca plc Corporation Information
12.6.2 Astra Zeneca plc Description and Business Overview
12.6.3 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Astra Zeneca plc Alzheimer’s Therapeutic Products Offered
12.6.5 Astra Zeneca plc Recent Development
12.7 Eli Lilly, Inc
12.7.1 Eli Lilly, Inc Corporation Information
12.7.2 Eli Lilly, Inc Description and Business Overview
12.7.3 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eli Lilly, Inc Alzheimer’s Therapeutic Products Offered
12.7.5 Eli Lilly, Inc Recent Development
12.8 F. Hoffman Le Roche
12.8.1 F. Hoffman Le Roche Corporation Information
12.8.2 F. Hoffman Le Roche Description and Business Overview
12.8.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Products Offered
12.8.5 F. Hoffman Le Roche Recent Development
12.9 Merck & Co
12.9.1 Merck & Co Corporation Information
12.9.2 Merck & Co Description and Business Overview
12.9.3 Merck & Co Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Merck & Co Alzheimer’s Therapeutic Products Offered
12.9.5 Merck & Co Recent Development
12.10 H. Lundbeck A/S
12.10.1 H. Lundbeck A/S Corporation Information
12.10.2 H. Lundbeck A/S Description and Business Overview
12.10.3 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 H. Lundbeck A/S Alzheimer’s Therapeutic Products Offered
12.10.5 H. Lundbeck A/S Recent Development
12.11 Pfizer Inc
12.11.1 Pfizer Inc Corporation Information
12.11.2 Pfizer Inc Description and Business Overview
12.11.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Inc Alzheimer’s Therapeutic Products Offered
12.11.5 Pfizer Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Alzheimer’s Therapeutic Industry Trends
13.2 Alzheimer’s Therapeutic Market Drivers
13.3 Alzheimer’s Therapeutic Market Challenges
13.4 Alzheimer’s Therapeutic Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alzheimer’s Therapeutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Alzheimer’s Therapeutic Market Insights, Forecast to 2027
List of TablesTable 1. Global Alzheimer’s Therapeutic Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Memantine Hydrochloride
Table 3. Major Manufacturers of Donepezil Hydrochloride
Table 4. Major Manufacturers of Rivastigmine
Table 5. Major Manufacturers of Galantamine Hydrobromide
Table 6. Global Alzheimer’s Therapeutic Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 7. Global Alzheimer’s Therapeutic Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Alzheimer’s Therapeutic Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Alzheimer’s Therapeutic Sales Market Share by Regions (2016-2021)
Table 10. Global Alzheimer’s Therapeutic Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Alzheimer’s Therapeutic Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Alzheimer’s Therapeutic Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Alzheimer’s Therapeutic Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Alzheimer’s Therapeutic Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Alzheimer’s Therapeutic Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Alzheimer’s Therapeutic Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Alzheimer’s Therapeutic Manufacturers by Revenue (US$ Million) in 2020
Table 18. Alzheimer’s Therapeutic Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Alzheimer’s Therapeutic Revenue Share by Manufacturers (2016-2021)
Table 20. Global Alzheimer’s Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Alzheimer’s Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Therapeutic as of 2020)
Table 22. Key Manufacturers Alzheimer’s Therapeutic Price (2016-2021) (USD/Pcs)
Table 23. Alzheimer’s Therapeutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Alzheimer’s Therapeutic Product Type
Table 25. Date of International Manufacturers Enter into Alzheimer’s Therapeutic Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Alzheimer’s Therapeutic Sales by Type (2016-2021) (K Pcs)
Table 28. Global Alzheimer’s Therapeutic Sales Share by Type (2016-2021)
Table 29. Global Alzheimer’s Therapeutic Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Alzheimer’s Therapeutic Revenue Share by Type (2016-2021)
Table 31. Alzheimer’s Therapeutic Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Alzheimer’s Therapeutic Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Alzheimer’s Therapeutic Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Alzheimer’s Therapeutic Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Alzheimer’s Therapeutic Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Alzheimer’s Therapeutic Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Alzheimer’s Therapeutic Sales by Application (2016-2021) (K Pcs)
Table 38. Global Alzheimer’s Therapeutic Sales Share by Application (2016-2021)
Table 39. Global Alzheimer’s Therapeutic Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Alzheimer’s Therapeutic Revenue Share by Application (2016-2021)
Table 41. Alzheimer’s Therapeutic Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 42. Global Alzheimer’s Therapeutic Sales Forecast by Application (2022-2027) & (K Pcs)
Table 43. Global Alzheimer’s Therapeutic Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Alzheimer’s Therapeutic Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Alzheimer’s Therapeutic Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Alzheimer’s Therapeutic Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 47. United States Alzheimer’s Therapeutic Sales (K Pcs) of Key Companies (2016-2021)
Table 48. United States Alzheimer’s Therapeutic Sales Share by Company (2016-2021)
Table 49. United States Alzheimer’s Therapeutic Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Alzheimer’s Therapeutic Revenue Share by Company (2016-2021)
Table 51. United States Alzheimer’s Therapeutic Sales (K Pcs) by Type (2016-2021)
Table 52. United States Alzheimer’s Therapeutic Sales Share by Type (2016-2021)
Table 53. United States Alzheimer’s Therapeutic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Alzheimer’s Therapeutic Price (USD/Pcs) by Type (2016-2021)
Table 55. United States Alzheimer’s Therapeutic Sales (K Pcs) by Type (2022-2027)
Table 56. United States Alzheimer’s Therapeutic Sales Share by Type (2022-2027)
Table 57. United States Alzheimer’s Therapeutic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Alzheimer’s Therapeutic Revenue Share by Type (2022-2027)
Table 59. United States Alzheimer’s Therapeutic Price (USD/Pcs) by Type (2022-2027)
Table 60. United States Alzheimer’s Therapeutic Sales (K Pcs) by Application (2016-2021)
Table 61. United States Alzheimer’s Therapeutic Sales Share by Application (2016-2021)
Table 62. United States Alzheimer’s Therapeutic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Alzheimer’s Therapeutic Price (USD/Pcs) by Application (2016-2021)
Table 64. United States Alzheimer’s Therapeutic Sales (K Pcs) by Application (2022-2027)
Table 65. United States Alzheimer’s Therapeutic Sales Share by Application (2022-2027)
Table 66. United States Alzheimer’s Therapeutic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Alzheimer’s Therapeutic Revenue Share by Application (2022-2027)
Table 68. United States Alzheimer’s Therapeutic Price (USD/Pcs) by Application (2022-2027)
Table 69. North America Alzheimer’s Therapeutic Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Alzheimer’s Therapeutic Sales Market Share by Country (2016-2021)
Table 71. North America Alzheimer’s Therapeutic Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Alzheimer’s Therapeutic Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Alzheimer’s Therapeutic Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Alzheimer’s Therapeutic Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Alzheimer’s Therapeutic Revenue Market Share by Region (2016-2021)
Table 77. Europe Alzheimer’s Therapeutic Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Alzheimer’s Therapeutic Sales Market Share by Country (2016-2021)
Table 79. Europe Alzheimer’s Therapeutic Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Alzheimer’s Therapeutic Revenue Market Share by Country (2016-2021)
Table 81. Latin America Alzheimer’s Therapeutic Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Alzheimer’s Therapeutic Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Alzheimer’s Therapeutic Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Alzheimer’s Therapeutic Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Alzheimer’s Therapeutic Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Inc Corporation Information
Table 90. Pfizer Inc Description and Business Overview
Table 91. Pfizer Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. Pfizer Inc Alzheimer’s Therapeutic Product
Table 93. Pfizer Inc Recent Development
Table 94. Novartis International AG Corporation Information
Table 95. Novartis International AG Description and Business Overview
Table 96. Novartis International AG Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. Novartis International AG Product
Table 98. Novartis International AG Recent Development
Table 99. Axovant Sciences Ltd Corporation Information
Table 100. Axovant Sciences Ltd Description and Business Overview
Table 101. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Axovant Sciences Ltd Product
Table 103. Axovant Sciences Ltd Recent Development
Table 104. Acadia Pharmaceuticals, Inc Corporation Information
Table 105. Acadia Pharmaceuticals, Inc Description and Business Overview
Table 106. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Acadia Pharmaceuticals, Inc Product
Table 108. Acadia Pharmaceuticals, Inc Recent Development
Table 109. Biotie Therapies Corporation Information
Table 110. Biotie Therapies Description and Business Overview
Table 111. Biotie Therapies Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. Biotie Therapies Product
Table 113. Biotie Therapies Recent Development
Table 114. Astra Zeneca plc Corporation Information
Table 115. Astra Zeneca plc Description and Business Overview
Table 116. Astra Zeneca plc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Astra Zeneca plc Product
Table 118. Astra Zeneca plc Recent Development
Table 119. Eli Lilly, Inc Corporation Information
Table 120. Eli Lilly, Inc Description and Business Overview
Table 121. Eli Lilly, Inc Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. Eli Lilly, Inc Product
Table 123. Eli Lilly, Inc Recent Development
Table 124. F. Hoffman Le Roche Corporation Information
Table 125. F. Hoffman Le Roche Description and Business Overview
Table 126. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. F. Hoffman Le Roche Product
Table 128. F. Hoffman Le Roche Recent Development
Table 129. Merck & Co Corporation Information
Table 130. Merck & Co Description and Business Overview
Table 131. Merck & Co Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Merck & Co Product
Table 133. Merck & Co Recent Development
Table 134. H. Lundbeck A/S Corporation Information
Table 135. H. Lundbeck A/S Description and Business Overview
Table 136. H. Lundbeck A/S Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 137. H. Lundbeck A/S Product
Table 138. H. Lundbeck A/S Recent Development
Table 139. Takeda Pharmaceutical Company Ltd Corporation Information
Table 140. Takeda Pharmaceutical Company Ltd Description and Business Overview
Table 141. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 142. Takeda Pharmaceutical Company Ltd Product
Table 143. Takeda Pharmaceutical Company Ltd Recent Development
Table 144. Alzheimer’s Therapeutic Market Trends
Table 145. Alzheimer’s Therapeutic Market Drivers
Table 146. Alzheimer’s Therapeutic Market Challenges
Table 147. Alzheimer’s Therapeutic Market Restraints
Table 148. Alzheimer’s Therapeutic Customers List
Table 149. Alzheimer’s Therapeutic Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer’s Therapeutic Product Picture
Figure 2. Global Alzheimer’s Therapeutic Sales Market Share by Type in 2020 & 2027
Figure 3. Memantine Hydrochloride Product Picture
Figure 4. Donepezil Hydrochloride Product Picture
Figure 5. Rivastigmine Product Picture
Figure 6. Galantamine Hydrobromide Product Picture
Figure 7. Global Alzheimer’s Therapeutic Sales Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinic
Figure 10. Other
Figure 11. Alzheimer’s Therapeutic Report Years Considered
Figure 12. Global Alzheimer’s Therapeutic Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Alzheimer’s Therapeutic Market Size 2016-2027 (US$ Million)
Figure 14. Global Alzheimer’s Therapeutic Sales 2016-2027 (K Pcs)
Figure 15. Global Alzheimer’s Therapeutic Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Alzheimer’s Therapeutic Sales Market Share by Region (2016-2021)
Figure 17. Global Alzheimer’s Therapeutic Sales Market Share by Region in 2020
Figure 18. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2016-2021)
Figure 19. Global Alzheimer’s Therapeutic Revenue Market Share by Region in 2020
Figure 20. Global Alzheimer’s Therapeutic Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Alzheimer’s Therapeutic Revenue in 2020
Figure 22. Alzheimer’s Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Alzheimer’s Therapeutic Sales Market Share by Type (2016-2021)
Figure 24. Global Alzheimer’s Therapeutic Sales Market Share by Type in 2020
Figure 25. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2016-2021)
Figure 26. Global Alzheimer’s Therapeutic Revenue Market Share by Type in 2020
Figure 27. Global Alzheimer’s Therapeutic Sales Market Share by Application (2016-2021)
Figure 28. Global Alzheimer’s Therapeutic Sales Market Share by Application in 2020
Figure 29. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2016-2021)
Figure 30. Global Alzheimer’s Therapeutic Revenue Market Share by Application in 2020
Figure 31. United States Alzheimer’s Therapeutic Sales Growth Rate 2016-2027 (K Pcs)
Figure 32. United States Alzheimer’s Therapeutic Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Alzheimer’s Therapeutic Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Alzheimer’s Therapeutic Players Market Share by Revenue in Alzheimer’s Therapeutic in 2020
Figure 35. United States Alzheimer’s Therapeutic Revenue Share by Type (2016-2021)
Figure 36. United States Alzheimer’s Therapeutic Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Alzheimer’s Therapeutic Revenue Share by Application (2016-2021)
Figure 38. United States Alzheimer’s Therapeutic Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Alzheimer’s Therapeutic Sales Growth Rate 2016-2021 (K Pcs)
Figure 40. North America Alzheimer’s Therapeutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Alzheimer’s Therapeutic Sales Market Share by Country in 2020
Figure 42. North America Alzheimer’s Therapeutic Revenue Market Share by Country in 2020
Figure 43. U.S. Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. U.S. Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. Canada Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Alzheimer’s Therapeutic Sales Growth Rate 2016-2021 (K Pcs)
Figure 48. Europe Alzheimer’s Therapeutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Alzheimer’s Therapeutic Sales Market Share by Country in 2020
Figure 50. Europe Alzheimer’s Therapeutic Revenue Market Share by Country in 2020
Figure 51. Germany Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. Germany Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. France Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. U.K. Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Italy Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Russia Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Alzheimer’s Therapeutic Sales Growth Rate 2016-2021 (K Pcs)
Figure 62. Asia Pacific Alzheimer’s Therapeutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Region in 2020
Figure 64. Asia Pacific Alzheimer’s Therapeutic Revenue Market Share by Region in 2020
Figure 65. China Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. China Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. Japan Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. South Korea Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. India Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. Australia Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Taiwan Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Indonesia Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Thailand Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Malaysia Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Philippines Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Vietnam Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Alzheimer’s Therapeutic Sales Growth Rate 2016-2021 (K Pcs)
Figure 88. Latin America Alzheimer’s Therapeutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Alzheimer’s Therapeutic Sales Market Share by Country in 2020
Figure 90. Latin America Alzheimer’s Therapeutic Revenue Market Share by Country in 2020
Figure 91. Mexico Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 92. Mexico Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Brazil Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Argentina Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate 2016-2021 (K Pcs)
Figure 98. Middle East and Africa Alzheimer’s Therapeutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Country in 2020
Figure 101. Turkey Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 102. Turkey Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 104. Saudi Arabia Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. UAE Alzheimer’s Therapeutic Sales Growth Rate (2016-2021) (K Pcs)
Figure 106. UAE Alzheimer’s Therapeutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Alzheimer’s Therapeutic Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Keyplayers in Global and United States Alzheimer’s Therapeutic Market Insights, Forecast to 2027
Pfizer IncNovartis International AG
Axovant Sciences Ltd
Acadia Pharmaceuticals, Inc
Biotie Therapies
Astra Zeneca plc
Eli Lilly, Inc
F. Hoffman Le Roche
Merck & Co
H. Lundbeck A/S
Takeda Pharmaceutical Company Ltd